Latest Selling Leads
.
| Date | Name/CAS No. | Suppliers/Manufactures | Check | ||
|---|---|---|---|---|---|
| 04-15 09:56 | Erenumab 1582205-90-0 |
||||
| 04-15 09:56 | Birtamimab 1608108-91-3 |
||||
| 04-15 09:56 | Suptavumab 1629615-23-1 |
||||
| 04-15 09:56 | Ficlatuzumab 1174900-84-5 |
||||
| 04-15 09:56 | Indatuximab Ravtansine 1238517-16-2 |
||||
| 04-15 09:56 | Caplacizumab 915810-67-2 |
||||
| 04-15 09:56 | Flanvotumab 1188277-05-5 |
||||
| 04-15 09:56 | Solitomab 1005198-65-1 |
||||
| 04-15 09:56 | Quilizumab 1228538-47-3 |
||||
| 04-15 09:56 | Patritumab 1262787-83-6 |
||||
| 04-15 09:56 | Onartuzumab 1133766-06-9 |
||||
| 04-15 09:56 | Ponezumab 1178862-65-1 |
||||
| 04-15 09:56 | Radretumab 1253180-81-2 |
||||
| 04-15 09:56 | Tregalizumab 1207446-68-1 |
||||
| 04-15 09:56 | Ublituximab 1174014-05-1 |
||||
| 04-15 09:56 | Vesencumab 1205533-60-3 |
||||
| 04-15 09:56 | Blosozumab 1132758-87-2 |
||||
| 04-15 09:56 | Crenezumab 1095207-05-8 |
||||
| 04-15 09:56 | Ozoralizumab 1167985-17-2 |
||||
| 04-15 09:56 | Oxelumab 1186098-83-8 |
